Capsaicinoids supplementation decreases percent body fat and fat mass: adjustment using covariates in a post hoc analysis

Table 3 Percent change in fat mass compared between active and placebo groups using model generated means (LS Means)

Contrast	Treatment	N	LS Mean (SE)	LS Mean Difference (SE)	P Value
Without Baseline Covariates
Capsimax 2 mg vs Placebo	Capsimax 2 mg	27	2.44 (2.14)	−0.82	0.7860
Capsimax 2 mg vs Placebo	Placebo	28	3.26 (2.10)	−0.82	0.7860
Capsimax 4 mg vs Placebo	Capsimax 4 mg	22	−0.81 (2.37)	−4.07	0.2037
Capsimax 4 mg vs Placebo	Placebo	28	3.26 (2.10)	−4.07	0.2037
With Baseline Covariates
Capsimax 2 mg vs Placebo	Capsimax 2 mg	26	3.45 (2.79)	−2.43	0.5044
Capsimax 2 mg vs Placebo	Placebo	27	5.88 (2.76)	−2.43	0.5044
Capsimax 4 mg vs Placebo	Capsimax 4 mg	22	−0.80 (2.37)	−6.68	0.0487
Capsimax 4 mg vs Placebo	Placebo	27	5.88 (2.76)	−6.68	0.0487

Analysis “Without Baseline Covariates” was a One-way ANOVA model. Analysis “With Baseline Covariates” was a generalized linear model containing treatment, covariates and treatment x covariate interactions. Two subjects were lost to the “With Baseline Covariates” analysis due to missing values at baseline

ISSN: 2052-9538